Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety

Addiction(2023)10.1111/add.16180Source: DataRank Database

Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety is a research paper published in Addiction (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.68)OA: hybridTopics (52)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Penn Whitley,Eric Dawson ORCID,Steven D. Passik,Adam J. Gordon ORCID,Bradley D. Stein ORCID

Live enrichment

PubMed:37158468 PMC:PMC10330099 OpenAlex:https://openalex.org/W4375954923

National Institute on Drug Abuse

Grant: R01DA045800

Institute of Development and Economic Alternatives

Grant: CIN 13‐414

NIDA NIH HHS

Grant: K01 DA042139

NIDA NIH HHS

Grant: UG1 DA049444

FWCI

5.68

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/add.16180

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/add.16180

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/add.16180

journalhttps://doi.org/10.1111/add.16180

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37158468

Fields of Study

Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesForensic Toxicology and Drug AnalysisHumansUnited StatesMethadoneAnalgesics, OpioidHeroinRetrospective StudiesChromatography, LiquidPatient SafetyTandem Mass SpectrometryOpioid-Related DisordersFentanylCocaineMethamphetamine

MeSH Terms

Analgesics, OpioidChromatography, LiquidCocaineHeroinFentanylHumansMethadoneMethamphetamineOpioid-Related DisordersRetrospective StudiesUnited StatesTandem Mass SpectrometryPatient Safety

Keywords

Polysubstance dependenceOpioid use disorderHeroinMedicineMethadoneSubstance abuseFentanylPopulationGeneralized estimating equationRate ratioGeeUrineInternal medicineEmergency medicinePsychiatryOpioidDrugAnesthesiaEnvironmental healthCocaineMethadone MaintenancePolysubstance UseUrine Drug Testing

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

10.6084/m9.figshare.26610786.v1figshare

Additional file 1 of The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

10.6084/m9.figshare.26610786figshare

Additional file 2 of The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

10.6084/m9.figshare.26610789.v1figshare

Additional file 2 of The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

10.6084/m9.figshare.26610789figshare